IPO - AYTU BIOPHARMA, INC

Form Type: S-1

Filing Date: 2025-06-02

Corporate Action: Ipo

Type: New

Accession Number: 000143774925019189

Filing Summary: On June 2, 2025, Aytu Biopharma, Inc. filed a registration statement on Form S-1 with the SEC. This registration is intended for an initial public offering of the company's securities. Aytu BioPharma is headquartered in Denver, Colorado, and the filing seeks to raise capital primarily for future business development. The company has specified various financial figures related to its operations and assets, indicating it desires to leverage this public offering to strengthen its capital structure and fund ongoing projects. The registration statement outlines the legal and administrative details necessary for compliance with the Securities Act of 1933, noting that securities will be offered as soon as practicable after the registration's effective date. Key individuals and firms involved in the process have been identified, reflecting the company's active engagement with financial advisors and legal counsel to navigate the IPO process.